Krsnaa Diagnostics Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹933-₹954
- Lot size
- 15 shares
- Issue amount
- ₹1,213 cr
- Total subscription
- 0×
- Opens
- 4 Aug 2021
- Closes
- 6 Aug 2021
- Allotment
- 12 Aug 2021
- Listing
- 16 Aug 2021
Offer at a glance
Issue overview
- Issue size
- 1,27,31,605 shares
- Face value
- ₹5 per share
- Minimum investment
- ₹13,995
- Fresh issue
- ₹401 cr
- Offer for sale
- ₹812 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,310
- Issue type
- Bookbuilding IPO
- Shares before issue
- 2,71,91,528
- Shares after issue
- 3,14,07,044
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 15 | ₹14,310 |
| sHNI | 13 | 210 | ₹2,00,340 |
| bHNI | 70 | 1,050 | ₹10,01,700 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Company information
Company profile
Incorporated in 2010, Krsnaa Diagnostics Ltd is one of India’s fastest-growing diagnostic chains, offering a wide range of services including imaging/radiology (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology to hospitals, medical colleges, and community health centres. The company has a strong presence in non-metro and lower-tier cities, operating 1,801 diagnostic centres across 13 cities as of December 31, 2020. In fiscal 2020, Krsnaa Diagnostics served approximately 5.27 million patients.
Strengths
- Differentiated Provider: Offers unique diagnostic services in India.
- Comprehensive Services: Covers imaging, pathology, and more.
- Strong Brand: Recognized for quality healthcare at affordable prices.
- Wide Market Presence: Operations across 13 states in India.
- Consistent Financials: Demonstrates a stable track record of performance.
Promoters
Rajendra Mutha
Registrar & documents
Lead manager
Dam Capital Advisors Limited, Equirus Capital Private Limited, IIFL Capital Services Limited, Jm Financial Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1, Chinchwad, Taluka – Haveli, Pune - 411 019
+91 20 4695 4695
[email protected]Company website ↗Frequently Asked Questions
What is Krsnaa Diagnostics IPO GMP today?
As of today, Krsnaa Diagnostics IPO Grey Market Premium (GMP) is reported at +₹222 per share. Based on the upper price band of ₹954, the estimated listing price is ₹1,176 (+23.3% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Krsnaa Diagnostics IPO?
The minimum bid lot size for Krsnaa Diagnostics IPO is 15 shares. At the cut-off price of ₹954 per share, retail investors need a minimum application amount of ₹14,310 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).
When will Krsnaa Diagnostics IPO allotment status be announced?
The allotment status for Krsnaa Diagnostics IPO is scheduled to be finalized on 12 Aug 2021. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Kfin Technologies Limited's official portal or via BSE/NSE allotment portals.
How can I check Krsnaa Diagnostics IPO allotment status online by PAN?
To check Krsnaa Diagnostics IPO allotment status: 1) Visit the registrar portal (Kfin Technologies Limited) or the BSE IPO allotment page. 2) Select 'Krsnaa Diagnostics Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.